Neuroendocrinology News

NEW ORLEANS — Medical advancements have come a long way in the past century, but it is in the next 80 years that we may see tremendous breakthroughs in eliminating human disease — at least that is the goal for the Chan Zuckerberg Initiative.

It takes some creativity to produce meaningful change in the practice of endocrinology. Whether in the laboratory or the clinic, being able to find solutions that may not be readily apparent is critical. That’s why innovators like John J. Kopchick, MS, PhD, play important roles in expanding and improving the field of endocrinology. The Endocrine Society is recognizing that role by presenting Kopchick with its Innovation Award at ENDO 2019 for his work in growth hormone research.

Short sleep duration is associated with increased BMI, but connections with cortisol production seen in adults are not apparent in children, according to findings published in Obesity.

Sleeping in during weekends to “catch up” on missed sleep during the week will not prevent weight gain or improve a reduction insulin sensitivity associated with sleeping less than 5 hours per night, according to findings from a small cohort study published in Current Biology.

An analysis of Swedish registry data revealed that approximately half of 1,300 patients identified as having Cushing’s disease were misdiagnosed, according to findings published in Pituitary.

A real-world analysis of adults with acromegaly suggests that most patients prescribed the growth hormone blocker pegvisomant take the drug as directed but that one-third make critical dosing errors, potentially affecting disease control, according to findings published in Pituitary.

The use of 3D-printed models could lead to less operation time and blood loss and fewer postoperative complications in adults who undergo endoscopic endonasal transsphenoidal surgery for pituitary adenomas and other conditions, according to findings published in Pituitary.

Adults with acromegaly may be prone to developing nodular thyroid disease and advanced nodule growth, according to findings published in Pituitary.

Pituitary tumor management via ongoing MRIs is recommended by most endocrinologists and pituitary neurosurgeons, but there is a need to improve understanding of the safety concerns surrounding gadolinium-based contrast agents, according to findings published in Pituitary.

Adults with thyroid-stimulating hormone-secreting pituitary adenomas have a greater chance of biochemical remission after undergoing adjuvant treatment compared with neoadjuvant therapies, according to findings published in Pituitary.